CABOZANIB 80 MG
CABOZANIB 80 MG/*54745756836*/
CABOZANIX 20 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
CABOZANIX 60 MG
CABOZANIX 60 MG/*54745756836*/
CABOZANIX 80 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
CAZER 80 _ 20 MG
CAZER 80 _ 20 MG/*54745756836*/
COVIRIN 200MG
Covirin Capsule 200 mg Indications Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with
CRIZOCENT 250 MG
Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including
CRIZONIX 250 MG
Crizonix Capsule 250 mg Indications Crizotinib is a kinase inhibitor indicated for the treatment of patients with- Metastatic non-small cell lung
DACLAXEN 60 MG
Indications Daclatasvir is indicated in combination with Sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection in adults.
DISANIX 20
DISANIX 20/*54745756836*/
Elbonix 50
COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
ELOPAG 50 MG
Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd. Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic